In that study, the author found that one of the factors associated with treatment failure was non-compliance with more than 80% of all prescribed medication, and this accounted for 25.2% in that study.[36] Unlike the findings of our present study, the triple-drug (SOF+Peg-IFN+RBV) regimen for 12 weeks was generally well tolerated, although 55.7% of patients had cirrhosis. The gene discussed is IFNA1; the disease is Cirrhosis.